OUR SERVICES
We provide solutions for pharma, biotech and food companies as end-to-end projects based on our robust scientific skills and full laboratory capabilities.
End-to-End Microbiome Projects
Our talented team has more than two decades of experience developing R&D projects on microbiome, probiotics, molecular biology and bioinformatics.
We have ensembled a world class, highly-qualified scientific team with PhD level scientists and computational biologists, so Microviable can be your preferred microbial expert.
We develop best-in-class tailored projects for pharma, biotech and food industry based on our extensive expertise, from study design to sample processing, data analysis and product development. We combine dry lab and wet lab, in house, to fit our clients’ needs.
Our laboratory facilities enable us to perform any project combining bioinformatics, microbiology, immunology and molecular biology, from strain targeted isolation and characterization with advanced expertise in anaerobic bacteria, to in vitro testing and functional assays harnessing a wide range of techniques.
Talk to us and together we will define your project for your success.


High-resolution metagenomics analysis to unravel the composition and functionality of the microbiome using next generation sequencing technologies coupled with advanced bioinformatics.
Our semi-automatized bioinformatic pipeline is fully optimized for microbiome analysis (shotgun metagenomics and 16S) including taxonomy, functional metabolic pathways, metagenome-assembled genomes (MAGs), comparative analyses and comprehensive statistics. Tailored with cloud computing, provides us limitless computational power enabling big data analyses from research cohorts to clinical studies with no leak in data security.
We offer a full-service solution from study design to sample processing in our laboratory facilities, together with data analysis and a comprehensive report.
High-resolution metagenomics analysis to unravel the composition and functionality of the microbiome using next generation sequencing technologies coupled with advanced bioinformatics.
Our semi-automatized bioinformatic pipeline is fully optimized for microbiome analysis (shotgun metagenomics and 16S) including taxonomy, functional metabolic pathways, metagenome-assembled genomes (MAGs), comparative analyses and comprehensive statistics. Tailored with cloud computing, provides us limitless computational power enabling big data analyses from research cohorts to clinical studies with no leak in data security.
We offer a full-service solution from study design to sample processing in our laboratory facilities, together with data analysis and a comprehensive report.

As a service provider, we are developing next generation biotherapeutics and novel probiotics bringing solutions into pharma and food supplements.
Combining our PharmaBiota® platform for microbiota-derived drug development and our proprietary bacterial culture collection, with more than two thousand isolates from three hundred different bacterial species, we can develop your next generation biotherapeutic product including biological drugs, live biotherapeutic products (LBPs), probiotics, postbiotics and other modalities.
Our world class microbiology expertise combined with in house laboratory capabilities, and a comprehensive platform for isolation, characterization and validation of bacterial strains will get the product you need.
We are ready for assisting you on the development of your novel biotherapeutics product as well as out-licensing some of our bacterial strains.
